Lilly Completes Acquisition of Prevail Therapeutics
INDIANAPOLIS, Jan. 22, 2021 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE:LLY) today announced the successful completion of its acquisition of Prevail Therapeutics Inc. (NASDAQ: PRVL). The acquisition establishes a new modality ... Biopharmaceuticals, Neurology, Mergers & Acquisitions Eli Lilly, Prevail Therapeutics, Parkinson's disease, Gaucher disease
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Brain | Gaucher's Disease | Marketing | Mergers and Aquisitions | Neurology | Parkinson's Disease | Pharmaceuticals